Ligand id: 6780

Name: rituximab

IUPHAR Pharmacology Education Project (PEP) logo

View more information in the IUPHAR Pharmacology Education Project: rituximab

Compound class Antibody
Approved drug? Yes (FDA (1997), EMA (1998))
International Nonproprietary Names
INN number INN
7609 rituximab
HSDB 7455 | MabThera® | Rituxan®
Database Links
Specialist databases
IMGT/mAb-DB 161
Other databases
PubChem SID 178103386
Search PubMed clinical trials rituximab
Search PubMed titles rituximab
Search PubMed titles/abstracts rituximab
Wikipedia Rituximab
Rituximab is a type I anti-CD20 monoclonal, designed to target surface CD20 on B-lymphocytes.
Annotated peptide sequences for this antibody are available from its IMGT/mAb-DB record.
Biosimilar PF-05280586 is in development [8] (evaluated in clinical trial NCT01526057).